Literature DB >> 20231732

The death knoll for the MMSE: has it outlived its purpose?

Ruth E Nieuwenhuis-Mark1.   

Abstract

The Mini-Mental State Examination (MMSE) is arguably the best-known cognitive screen in the world. Originally designed to assess cognitive impairment in elderly populations, it has become one of the first steps toward a dementia diagnosis. Routinely used in the clinic and in research internationally, the MMSE, despite its flaws, has managed to retain its popularity for more than 30 years. This review explores when and how the test is used, lists its advantages and disadvantages, and ultimately questions its value. The specific issue that is addressed here is whether the test has outlived its original purpose. The conclusion is that although the MMSE may be a useful tool in many circumstances where a cognitive screen is required, practitioners should be wary of using MMSE total scores as a shortcut toward a dementia diagnosis.

Entities:  

Mesh:

Year:  2010        PMID: 20231732     DOI: 10.1177/0891988710363714

Source DB:  PubMed          Journal:  J Geriatr Psychiatry Neurol        ISSN: 0891-9887            Impact factor:   2.680


  31 in total

1.  Development of a Multidimensional Functional Health Scale for Older Adults in China.

Authors:  Fanzhen Mao; Yaofeng Han; Junze Chen; Wei Chen; Manqiong Yuan; Y Alicia Hong; Ya Fang
Journal:  Community Ment Health J       Date:  2015-11-04

2.  The Modified Telephone Interview for Cognitive Status is More Predictive of Memory Abilities Than the Mini-Mental State Examination.

Authors:  Kevin Duff; Danielle Tometich; Kathryn Dennett
Journal:  J Geriatr Psychiatry Neurol       Date:  2015-02-26       Impact factor: 2.680

3.  The effects of depression, anxiety and sleep disturbances on cognitive impairment in patients with chronic obstructive pulmonary disease.

Authors:  Yesim Güzey Aras; Abdülkadir Tunç; Belma Doğan Güngen; Adil Can Güngen; Yusuf Aydemir; Bekir Enes Demiyürek
Journal:  Cogn Neurodyn       Date:  2017-08-05       Impact factor: 5.082

4.  [Polarity of the freely formulated MMST sentence and state of health of people with dementia : Results of a cross-sectional study].

Authors:  Stefan Sniatecki; Gabriele Meyer; Anna Renom-Guiteras; Martin N Dichter; Herbert Mayer; Astrid Stephan
Journal:  Z Gerontol Geriatr       Date:  2016-05-12       Impact factor: 1.281

Review 5.  Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI).

Authors:  Ingrid Arevalo-Rodriguez; Nadja Smailagic; Marta Roqué I Figuls; Agustín Ciapponi; Erick Sanchez-Perez; Antri Giannakou; Olga L Pedraza; Xavier Bonfill Cosp; Sarah Cullum
Journal:  Cochrane Database Syst Rev       Date:  2015-03-05

6.  Social disorder, APOE-E4 genotype, and change in cognitive function among older adults living in Chicago.

Authors:  Jason D Boardman; Lisa L Barnes; Robert S Wilson; Denis A Evans; Carlos F Mendes de Leon
Journal:  Soc Sci Med       Date:  2012-03-13       Impact factor: 4.634

7.  Evaluating PROMIS(®) applied cognition items in a sample of older adults at risk for cognitive decline.

Authors:  Molly Howland; Curtis Tatsuoka; Kathleen A Smyth; Martha Sajatovic
Journal:  Psychiatry Res       Date:  2016-11-01       Impact factor: 3.222

8.  Normative data for the ACE-R in an Italian population sample.

Authors:  Martina Pigliautile; Francesca Chiesi; Sonia Rossetti; Manuela Conestabile Della Staffa; Monica Ricci; Stefano Federici; Dora Chiloiro; Caterina Primi; Patrizia Mecocci
Journal:  Neurol Sci       Date:  2015-07-28       Impact factor: 3.307

9.  Quantitative and qualitative features of executive dysfunction in frontotemporal and Alzheimer's dementia.

Authors:  Andrew M Kiselica; Jared F Benge
Journal:  Appl Neuropsychol Adult       Date:  2019-08-19       Impact factor: 2.248

10.  A new scoring system for increasing the sensitivity of the MMSE.

Authors:  Lisa Hahn; Josef Kessler
Journal:  Z Gerontol Geriatr       Date:  2019-02-25       Impact factor: 1.281

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.